ONESOURCE SPECIALTY PHARMA
Back to Cashflow Statement
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹359 Cr | ₹412 Cr | ₹-391 Cr | ₹118 Cr | ₹1,162 Cr |
What is the latest Cash Flow from Financing Activities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹359 Cr |
| Mar2025 | ₹412 Cr |
| Mar2024 | ₹-391 Cr |
| Mar2023 | ₹118 Cr |
| Mar2022 | ₹1,162 Cr |
How is Cash Flow from Financing Activities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹359 Cr | -12.76 | |
| Mar2025 | ₹412 Cr | Positive | |
| Mar2024 | ₹-391 Cr | Negative | |
| Mar2023 | ₹118 Cr | -89.82 | |
| Mar2022 | ₹1,162 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹17,930.5 Cr | 12% | -1.3% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 12% |
-1.3% |
-14.4% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses